Following a successful contribution to the methodological guidance development in EUnetHTA JA (2010-2012), EUnetHTA continued its efforts in JA2 as well.

Contribution to developing and testing a methodological basis for European cooperation on HTA including guidelines for distinct methodological issues was one of the objectives of the EUnetHTA JA2 (2012-2015). Set out “to develop a) methodological guidelines on pertinent issues of assessment (e.g. for devices) or update existing guidelines according to needs and resources or b) guidelines for improving evidence generation in early dialog with manufacturers or c) a uniform data template for submissions enabling sound, common rapid assessments and national adaptation”, by March 2016 EUnetHTA has delivered 5 new methodological guidelines on various subjects pertinent to the HTA production process and an update of the EUnetHTA JA (2010-2012) guidelines (please see a complete list of the EUnetHTA methodological guidelines until now).

EUnetHTA continues its efforts in the transition period between JA2 and JA3 to further its work on the methodological guidance for personalised medicine and encourages active contribution to EUnetHTA’s public consultation on the subject!

As a part of the methodological development work and as a lesson-learned experience in JA2, EUnetHTA highlights the importance of a constructive cooperation with contributing fields of research, research institutions and initiatives. Part of this effort is EUnetHTA’s contribution to outline a number of methodological issues which requires further research attention. EUnetHTA successfully cooperated with research groups on, eg, development of the methodological guideline on medical devices and continues to be active in a number of ongoing research initiatives, eg, IMI projects.